Last reviewed · How we verify
Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients (CLP-10095)
Assessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.
Details
| Lead sponsor | BioProtect |
|---|---|
| Status | COMPLETED |
| Enrolment | 175 |
| Start date | Thu Jun 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jan 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Prostate Cancer
Interventions
- Observation
Countries
Portugal, Poland